• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects

tetano

Editor, Senior Moderator
Cell Rep


. 2020 Sep 23;108254.
doi: 10.1016/j.celrep.2020.108254. Online ahead of print.
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects


Ya-Wen Cheng[SUP] 1 [/SUP], Tai-Ling Chao[SUP] 2 [/SUP], Chiao-Ling Li[SUP] 1 [/SUP], Mu-Fan Chiu[SUP] 1 [/SUP], Han-Chieh Kao[SUP] 2 [/SUP], Sheng-Han Wang[SUP] 3 [/SUP], Yu-Hao Pang[SUP] 2 [/SUP], Chih-Hui Lin[SUP] 2 [/SUP], Ya-Min Tsai[SUP] 2 [/SUP], Wen-Hau Lee[SUP] 2 [/SUP], Mi-Hua Tao[SUP] 4 [/SUP], Tung-Ching Ho[SUP] 1 [/SUP], Ping-Yi Wu[SUP] 4 [/SUP], Li-Ting Jang[SUP] 5 [/SUP], Pei-Jer Chen[SUP] 6 [/SUP], Sui-Yuan Chang[SUP] 7 [/SUP], Shiou-Hwei Yeh[SUP] 8 [/SUP]



Affiliations

Abstract

Development of specific antiviral agents is an urgent unmet need for SARS-coronavirus 2 (SARS-CoV-2) infection. This study focuses on host proteases that proteolytically activate the SARS-CoV-2 spike protein, critical for its fusion after binding to angiotensin-converting enzyme 2 (ACE2), as antiviral targets. We first validate cleavage at a putative furin substrate motif at SARS-CoV-2 spikes by expressing it in VeroE6 cells and find prominent syncytium formation. Cleavage and the syncytium are abolished by treatment with the furin inhibitors decanoyl-RVKR-chloromethylketone (CMK) and naphthofluorescein, but not by the transmembrane protease serine 2 (TMPRSS2) inhibitor camostat. CMK and naphthofluorescein show antiviral effects on SARS-CoV-2-infected cells by decreasing virus production and cytopathic effects. Further analysis reveals that, similar to camostat, CMK blocks virus entry, but it further suppresses cleavage of spikes and the syncytium. Naphthofluorescein acts primarily by suppressing viral RNA transcription. Therefore, furin inhibitors may be promising antiviral agents for prevention and treatment of SARS-CoV-2 infection.

Keywords: SARS-CoV-2; cytopathic effect; furin; spike; syncytium.
 
Back
Top Bottom